Fingolimod (GilenyaTM, FTY720-P)—a functional S1P1-antagonist—has been shown to improve the relapse rate in relapsing-remitting MS by preventing the egress of lymphocytes from the lymph nodes [12]. The gene discussed is S1PR1; the disease is relapsing-remitting multiple sclerosis.